Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v5-FR
Language English French
Date Updated 2018-04-04 2018-02-15
Drug Identification Number 02435810 02435810
Brand name EPINEPHRINE INJECTION EPINEPHRINE INJECTION
Common or Proper name EPINEPHRINE INJECTION EPINEPHRINE INJECTION
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients EPINEPHRINE EPINEPHRINE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS INTRACARDIAC INTRAMUSCULAR INTRATRACHEAL INTRAVENOUS SUBCUTANEOUS
Packaging size 1 mL 1 mL
ATC code C01CA C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-15 2017-11-15
Estimated end date 2018-05-15 2018-03-20
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments